News

Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook
Q2 2025 Management View Christopher M. Hall, CEO, stated the quarter was marked by "outstanding execution of our win in MRD ...